hologic , inc .
notes to consolidated financial statements ( continued ) ( in thousands , except per share data ) a new platform technology to analyze images and breast density measurement .
the projects were substantially completed as planned in fiscal 2007 .
the deferred income tax asset relates to the tax effect of acquired net operating loss carry forwards that the company believes are realizable partially offset by acquired identifiable intangible assets , and fair value adjustments to acquired inventory as such amounts are not deductible for tax purposes .
acquisition of suros surgical systems , inc .
on july 27 , 2006 , the company completed the acquisition of suros surgical systems , inc .
( 201csuros 201d ) , pursuant to an agreement and plan of merger dated april 17 , 2006 .
the results of operations for suros have been included in the company 2019s consolidated financial statements from the date of acquisition as part of its mammography/breast care business segment .
suros , located in indianapolis , indiana , develops , manufactures and sells minimally invasive interventional breast biopsy technology and products for biopsy , tissue removal and biopsy site marking .
the initial aggregate purchase price for suros of approximately $ 248100 ( subject to adjustment ) consisted of 4600 shares of hologic common stock valued at $ 106500 , cash paid of $ 139000 , and approximately $ 2600 for acquisition related fees and expenses .
the company determined the fair value of the shares issued in connection with the acquisition in accordance with eitf issue no .
99-12 , determination of the measurement date for the market price of acquirer securities issued in a purchase business combination .
the components and allocation of the final purchase price , consists of the following approximate amounts: .

Net tangible assets acquired as of July 27, 2006
$13,100
In-process research and development
4,900
Developed technology and know-how
46,000
Customer relationship
17,900
Trade name
5,800
Deferred income taxes
(21,300)
Goodwill
181,700
Final purchase price
$248,100

the acquisition also provides for a two-year earn out .
the earn-out is payable in two annual cash installments equal to the incremental revenue growth in suros 2019 business in the two years following the closing .
the company has considered the provision of eitf issue no .
95-8 , accounting for contingent consideration paid to the shareholders of and acquired enterprise in a purchase business combination , and concluded that this contingent consideration represents additional purchase price .
during the fourth quarter of fiscal 2007 the company paid approximately $ 19000 to former suros shareholders for the first annual earn-out period resulting in an increase to goodwill for the same amount .
the company also accrued $ 24500 for the second and final earn-out related to suros 2019 incremental revenue growth during the fourth quarter of fiscal 2008 , with an increase to goodwill , of which $ 24400 had been paid as of september 27 , 2008 .
in addition to the earn-out discussed above , the company decreased goodwill in the amount of $ 1300 during the year ended september 27 , 2008 and increased goodwill in the amount of $ 210 during the year ended september 29 , 2007 .
the increase in 2007 was primarily related to recording a liability of approximately $ 550 in accordance with eitf 95-3 related to the termination of certain employees who have ceased all services for the company .
approximately $ 400 of this liability was paid during the year ended september 29 , 2007 and the balance was paid during fiscal 2008 .
this increase was partially offset by a decrease to goodwill as a result of a change in the valuation of certain assets and liabilities acquired based on information received during the year ended september 29 , 2007 .
the decrease in goodwill during 2008 was related to the reduction of an income tax liability .
there have been no other material changes to purchase price allocations. .

Question: Analyse this data from a financial earnings document. what is the estimated price of hologic common stock used in the acquisition of suros?
Choices:
2315.21739
23.15217
10
193.63636
3944.44444
Correct choice index: 1